An interventional study of Epidural Spinal Cord Stimulation (scES) and Activity-Based Rehabilitation (ABT) in Spinal Cord Injuries (Complete and Incomplete), sponsored by Dr. Gabriel Zeilig. Not yet recruiting at 1 site in Israel. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Dr. Gabriel Zeilig · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Spinal Cord Injuries with a site in Israel — 6 open to participants now, 6 under way, none of them phase 3. Spinal Cord Injuries · Israel.
Among the 12 studies in Spinal Cord Injuries with a site in Israel, this one is the 9th largest by planned enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2027, is one of 7 with no phase, and was the 11th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →6 of the 12 studies in Spinal Cord Injuries with a site in Israel are open now. Recruiting first, the newest first:
Motion Informatics LTD · Sites in Israel
Ages 18+
Loewenstein Hospital · Sites in Israel
Ages 18+
St George's, University of London · Sites in Israel, Austria, Belgium and 9 more countries
Ages 16+
Loewenstein Hospital · Sites in Israel
Ages 18+
Dr. Gabriel Zeilig · Sites in Israel
Ages 18–65
A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 55 across the 10 interventional studies, 90 across the 2 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
4 of 12 have an industry lead sponsor. The 9 most frequent:
Dr. Gabriel Zeilig is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Dr. Gabriel Zeilig has 2 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
2 of the studies in Spinal Cord Injuries with a site in Israel that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07404761Motion Informatics LTDSafety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments | 2026-12-30 |
| NCT05484557Loewenstein HospitalPrevention of Thromboembolism Using Apixaban vs Enoxaparin Following Spinal Cord Injury | 2027-08 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Spinal Cord Injuries with a site in Israel, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot study aims to evaluate the safety and feasibility of epidural spinal cord stimulation (scES) combined with intensive rehabilitation in individuals with chronic spinal cord injury (SCI). The study will enroll up to 10 adults with spinal cord injury who are unable to walk independently in the community.
Participants will undergo surgical implantation of an epidural spinal cord stimulation system, followed by individualized stimulation programming and 80 sessions of activity-based rehabilitation focusing on voluntary lower extremity movements, standing, and stepping.
The primary objectives are to assess the safety of the implantation and stimulation procedures and the feasibility of implementing the rehabilitation protocol. Secondary objectives include evaluating potential changes in motor function, autonomic function, psychological well-being, and quality of life.
Participants will be followed for approximately 12 months, with repeated clinical and functional assessments throughout the study.
This prospective, single-arm, interventional pilot study will enroll up to 10 adults aged 18-65 years with chronic spinal cord injury at least 12 months post-injury. The study will be conducted at Sheba Medical Center.
Following screening and baseline assessments, eligible participants will undergo surgical implantation of an epidural electrode array (Medtronic Specify 5-6-5) and an implantable pulse generator (Medtronic Intellis). The electrode array will be positioned over the lumbosacral spinal cord to facilitate motor activation of the lower extremities.
Approximately 1-2 weeks after implantation, participants will undergo neurophysiological mapping to identify individualized electrode configurations and stimulation parameters. The StimX research system will be used to program stimulation patterns targeting voluntary movement, standing, and stepping.
Participants will then complete 80 sessions of intensive, task-specific rehabilitation combined with epidural stimulation, delivered approximately five days per week over 3-6 months. Training will include voluntary lower extremity movements, standing, stepping, transfers, and other functional tasks, with progression tailored to each participant's abilities and responses.
Clinical and functional assessments will be conducted at baseline and after 20, 40, 60, and 80 training sessions. Participants will be followed for approximately 12 months after implantation.
The primary outcomes will focus on safety and feasibility, including serious adverse events related to surgery or the device, recruitment and retention, successful stimulation mapping, and completion of planned training sessions.
Secondary assessments will examine voluntary motor control, standing and stepping performance, neurological status, muscle activation using electromyography (EMG), cardiovascular and other autonomic functions, psychological symptoms, and quality of life.
The study is designed primarily to establish safety and feasibility and to generate preliminary data to inform future clinical studies.
**Inclusion Criteria:**
**Exclusion Criteria:**
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants will undergo surgical implantation of an epidural spinal cord stimulation system, followed by individualized stimulation mapping and programming. Participants will then receive 80 sessions of activity-based rehabilitation combined with epidural stimulation, focusing on voluntary lower extremity movements, standing, and stepping. Follow-up will continue for approximately 12 months after implantation.
Device: Epidural Spinal Cord Stimulation (scES) · Other: Activity-Based Rehabilitation (ABT)
Surgical implantation of a Medtronic Specify 5-6-5 epidural electrode array over the lumbosacral spinal cord and a Medtronic Intellis implantable pulse generator. Stimulation will be individually programmed using the StimX research system. Electrode configurations and stimulation parameters will be optimized through neurophysiological mapping to facilitate voluntary lower extremity movements, standing, and stepping.
Individualized, task-specific rehabilitation combined with epidural spinal cord stimulation. Training will include voluntary lower extremity movements, standing, stepping, sit-to-stand practice, transfers, and other functional tasks. Participants will complete 80 training sessions over approximately 3-6 months, generally five sessions per week, with approximately one hour of active training per session.
Serious Adverse Events
* Title:\*\* Percentage of Participants Experiencing Device- or Surgery-Related Serious Adverse Events * Description:\*\* Percentage of implanted participants experiencing at least one serious adverse event related to the surgical procedure or implanted stimulation system. Serious adverse events will be recorded and assessed for their relationship to the procedure or device. * Time Frame:\*\* From implantation through 12 months after implantation.
Time frame: From implantation through 12 months after implantation.
Participant Recruitment Rate
Number of participants enrolled per month during the recruitment period.
Time frame: During the recruitment period (anticipated up to 12 months).
Retention at 6 Months
Percentage of enrolled participants who remain in the study at the 6-month follow-up.
Time frame: 6 months after implantation.
Retention at 12 Months
Percentage of enrolled participants who remain in the study at the 12-month follow-up
Time frame: 12 months after implantation.
Stimulation Mapping
Number of implanted participants who complete the planned postoperative neurophysiological mapping procedures to identify individualized electrode configurations and stimulation parameters
Time frame: During initial postoperative mapping, approximately 1-3 weeks after implantation
Number of Rehabilitation Training Sessions Completed
Number of completed rehabilitation training sessions per participant out of the 80 planned sessions combining activity-based rehabilitation with epidural spinal cord stimulation.
Time frame: During the rehabilitation period, approximately 3-6 months after initiation of training
Change in Neuromuscular Recovery Scale (NRS) Standing Task Rating
Change in standing performance assessed using the standing task rating of the Neuromuscular Recovery Scale (NRS), which evaluates motor performance and the level of assistance required without relying on compensatory movement strategies
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
Change in Neuromuscular Recovery Scale (NRS) Stepping Task Rating
Change in stepping performance assessed using the stepping task rating of the Neuromuscular Recovery Scale (NRS).
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
Neurological Motor Function
Change in neurological motor function assessed using the ISNCSCI examination. The total motor score ranges from 0 to 100, with higher scores indicating better motor function
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
Maximum Assisted Standing Duration Under Epidural Stimulation
Maximum duration in seconds that a participant can maintain assisted standing while receiving epidural spinal cord stimulation.
Time frame: After 40 training sessions (up to 3 months after training initiation) and after 80 training sessions (up to 6 months after training initiation). העתק
Depression (PHQ-9)
Change in depressive symptoms assessed using the 9-item Patient Health Questionnaire. Total scores range from 0 to 27, with higher scores indicating greater depressive symptom severity
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
Anxiety (GAD-7)
Change in anxiety symptoms assessed using the 7-item Generalized Anxiety Disorder scale. Total scores range from 0 to 21, with higher scores indicating greater anxiety symptom severity
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
PTSD (PCL-5)
Change in self-reported post-traumatic stress symptoms assessed using the PTSD Checklist for DSM-5. Total scores range from 0 to 80, with higher scores indicating greater symptom severity.
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
PTSD (CAPS-5)
Change in clinician-rated post-traumatic stress symptom severity assessed using the CAPS-5. Total severity scores range from 0 to 80, with higher scores indicating greater symptom severity.
Time frame: Baseline (before implantation), after 40 training sessions (up to 3 months after training initiation), and after 80 training sessions (up to 6 months after training initiation).
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for May 2027; primary completion for Dec 2028, 19 months later.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 19 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dr. Gabriel Zeilig